Pharma Business review is using cookies

ContinueLearn More
Close
August 15, 2018

Haplogen, Bayer enter into drug discovery and development collaboration

Haplogen and German pharma firm Bayer have entered into a collaboration to develop drug candidates for the treatment of chronic obstructive pulmonary disease (COPD) and other pulmonary diseases.